GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia.

ABSTRACT:

Background

Although the conventional, monopolar transurethral resection of the prostate (TURP) has proven to be an effective and relatively safe treatment for patients with benign prostatic hyperplasia (BPH), many new endoscopic technologies have been introduced to treat BPH. With the development of laser, there are several alternative transurethral procedures embracing laser therapies. Herein, this study sought to explore the efficacy, safety and follow-up of GreenLight laser photoselective vapo-enucleation of the prostate (PVEP) with front-firing emission compared with plasmakinetic resection of the prostate (PKRP) used to surgically manage BPH.

Methods

Data from patients who underwent either GreenLight laser PVEP or PKRP were retrospectively collected from March 2013 to M

SUBMITTER: Cheng X 

PROVIDER: S-EPMC7215003 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature